Cutivate Adverse Reactions





Zuellig Pharma
Full Prescribing Info
Adverse Reactions
Post-Marketing Data: Adverse drug reactions (ADRs) are listed as follows by MedDRA system organ class and by frequency. Frequencies are defined as: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000) and very rare (<1/10,000), including isolated reports.
Infections and infestations: Very rare: Opportunistic infection.
Immune system disorders: Very rare: Hypersensitivity.
Endocrine disorders: Very rare: Hypothalamic-pituitary-adrenal (HPA) axis suppression: Increased weight/obesity; Delayed weight gain/growth retardation in children; Cushingoid features (e.g. moon face, central obesity); Decreased endogenous cortisol levels; Hyperglycaemia/glucosuria; Hypertension; Osteoporosis; Cataract; Glaucoma.
Skin and subcutaneous tissue disorders: Common: Pruritus. Uncommon: Local skin burning. Very rare: Skin thinning, atrophy, striae, telangiectasias, pigmentation changes, hypertrichosis, allergic contact dermatitis, exacerbation of underlying symptoms, pustular psoriasis, erythema, rash, urticaria.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in